APA aipamena

Perez, A., Carrasco-Sánchez, F. J., González, C., Seguí-Ripoll, J. M., Trescolí, C., Ena, J., . . . Gomez Huelgas, R. (2020). Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: Results of the phase IV COBALTA trial. BMJ Open Diabetes Res Care.

Chicago Style aipamena

Perez, Antonio, Francisco Javier Carrasco-Sánchez, Carlos González, José Miguel Seguí-Ripoll, Carlos Trescolí, Javier Ena, Mireia Borrell, and Ricardo Gomez Huelgas. "Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) During Hospitalization and Therapy Intensification At Discharge in Patients With Insufficiently Controlled Type 2 Diabetes: Results of the Phase IV COBALTA Trial." BMJ Open Diabetes Res Care 2020.

MLA aipamena

Perez, Antonio, et al. "Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) During Hospitalization and Therapy Intensification At Discharge in Patients With Insufficiently Controlled Type 2 Diabetes: Results of the Phase IV COBALTA Trial." BMJ Open Diabetes Res Care 2020.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.